Stockpicker Comparison Tool
Nothing here is comparable yet for these companies.
Revenue Growth
BBIO
101.18%
▲ 34.41%
MRNA
2.11%
▼ -261.44%
Gross Margin
BBIO
93.24%
▼ -1.40%
MRNA
35.86%
▲ 181.36%
Free Cash Flow
BBIO
-$223.78M
▼ -$26.43M
MRNA
-$563.00M
▲ $129.00M
Net Debt / EBITDA
BBIO
-2.94
▲ 1.07
MRNA
1.36
▲ 0.01
Operating Margin
BBIO
-48.14%
▲ 6.33%
MRNA
-562.07%
▼ -205.26%
P/E Ratio
BBIO
—
MRNA
34.71
▲ 23.87